2N3 Stock Overview

Engages in the management and operation of health establishments. More details

2N3 fundamental analysis
Snowflake Score
Valuation	6/6
Future Growth	2/6
Past Performance	2/6
Financial Health	2/6
Dividends	3/6

Rewards

Trading at 81.3% below our estimate of its fair value

Earnings are forecast to grow 7.37% per year

Trading at good value compared to peers and industry

Analysts in good agreement that stock price will rise by 27.7%

Risk Analysis

Interest payments are not well covered by earnings

Unstable dividend track record

My Notes

Capture your thoughts, links and company narrative

LNA Santé SA Competitors

M1 Kliniken

XTRA:M12

€292.2m

RHÖN-KLINIKUM

XTRA:RHK

€923.8m

LIMES Schlosskliniken

XTRA:LIK

€95.0m

Gesundheitswelt Chiemgau

MUN:JTH

€23.8m

Price History & Performance

Summary of share price highs, lows and changes for LNA Santé
Historical stock prices
Current Share Price	€22.75
52 Week High	€27.20
52 Week Low	€18.12
Beta	0.77
1 Month Change	-2.15%
3 Month Change	0.89%
1 Year Change	16.43%
3 Year Change	-55.48%
5 Year Change	-53.52%
Change since IPO	-57.32%

Recent updates

Shareholder Returns

	2N3	DE Healthcare	DE Market
7D	-2.4%	-3.5%	-2.6%
1Y	16.4%	15.6%	6.9%

Return vs Industry: 2N3 matched the German Healthcare industry which returned 15.6% over the past year.

Return vs Market: 2N3 exceeded the German Market which returned 6.9% over the past year.

Price Volatility

Is 2N3's price volatile compared to industry and market?
2N3 volatility
2N3 Average Weekly Movement	3.8%
Healthcare Industry Average Movement	4.7%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	11.2%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 2N3 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: 2N3's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1990	7,835	Willy Siret	www.lna-sante.com

LNA Santé SA engages in the management and operation of health establishments. The company operates retirement homes, medical and rehabilitation care, home hospital, surgery, mental health clinic, and health center. LNA Santé SA was founded in 1990 and is based in Vertou, France.

LNA Santé SA Fundamentals Summary

How do LNA Santé's earnings and revenue compare to its market cap?
2N3 fundamental statistics
Market cap	€238.25m
Earnings (TTM)	€23.84m
Revenue (TTM)	€762.03m

10.0x

P/E Ratio

0.3x

P/S Ratio

Is 2N3 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2N3 income statement (TTM)
Revenue	€762.03m
Cost of Revenue	€513.70m
Gross Profit	€248.34m
Other Expenses	€224.50m
Earnings	€23.84m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	2.33
Gross Margin	32.59%
Net Profit Margin	3.13%
Debt/Equity Ratio	134.3%

How did 2N3 perform over the long term?

See historical performance and comparison

Dividends

2.6%

Current Dividend Yield

26%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 14:00
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

LNA Santé SA is covered by 18 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Beatrice Allen	Berenberg
Fraser Donlon	Berenberg
Stephane Sumar	BNP Paribas Exane